Clinical Trials Logo

Male Breast Cancer clinical trials

View clinical trials related to Male Breast Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05156606 Active, not recruiting - Male Breast Cancer Clinical Trials

Testosterone & Tamoxifen Trial

T&T
Start date: November 10, 2022
Phase: N/A
Study type: Interventional

This is a concise single arm, feasibility study, which will be executed in the University Medical Center Groningen, The Netherlands. Male patients with metastatic BC (n=6) are eligible for this study after at least 1 line of conventional endocrine therapy.

NCT ID: NCT03240510 Active, not recruiting - Male Breast Cancer Clinical Trials

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

Start date: January 1, 2014
Phase: N/A
Study type: Observational

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013. Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).

NCT ID: NCT02480933 Active, not recruiting - Male Breast Cancer Clinical Trials

Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens

SISYPHUS
Start date: September 2016
Phase: N/A
Study type: Interventional

The aim of this study is to define silent breast cancer prevalence in both sexes and will be held by biopsies performed in imaging suspicious areas of the breast (ecography and mammography) in cadavers without known breast cancer.

NCT ID: NCT01706432 Active, not recruiting - Liver Metastases Clinical Trials

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Start date: June 15, 2009
Phase:
Study type: Observational

This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

NCT ID: NCT01372579 Active, not recruiting - Clinical trials for Stage IIIA Breast Cancer

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Start date: August 2011
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well giving eribulin mesylate and carboplatin together before surgery works in treating patients with stage I-III triple-negative breast cancer. Drugs used in chemotherapy, such as eribulin mesylate and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

NCT ID: NCT00791037 Active, not recruiting - Clinical trials for HER2-positive Breast Cancer

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Start date: October 2008
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial is studying the side effects of escalating doses of adoptive T cell therapy in treating patients with stage IV breast cancer. Vaccines are given to patient prior the expansion of a person's white blood cells may help the body build an effective immune response to kill tumor cells that overexpress human epidermal growth factor receptor 2 (HER2)